Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes

Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes

The technologies for fabrication of nanocrystals have an immense potential to improve solubility of a variety of the poor water-soluble drugs with subsequent enhanced bioavailability. Repaglinide (Rp) is an antihyperglycemic drug having low bioavailability due to its extensive first-pass metabolism....

Full description

Bibliographic Details
Main Authors:	Mubashir Ahmad, Shahzeb Khan, Syed Muhammad Hassan Shah, Muhammad Zahoor, Zahid Hussain, Haya Hussain, Syed Wadood Ali Shah, Riaz Ullah, Amal Alotaibi
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Biomedicines
Subjects:	repaglinide (Rp) microfluidic technology in-vitro in-vivo study bioavailability rats
Online Access:	https://www.mdpi.com/2227-9059/11/4/1064

Similar Items

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
by: Kazuno Omori, et al.
Published: (2019-03-01)

Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets
by: Raja Navamanisubramanian, et al.
Published: (2020-12-01)

Repaglinide–Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box–Behnken Design, Characterization, and In Vivo Evaluation
by: Ali HSM, et al.
Published: (2024-01-01)

The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
by: Yaghoobian M, et al.
Published: (2020-11-01)

Oxidative stress in the testis of hyperglycemic rabbits treated with repaglinide
by: Gumieniczek Anna, et al.
Published: (2007-12-01)

Development of Novel S-Protective Thiolated-Based Mucoadhesive Tablets for Repaglinide: Pharmacokinetic Study
by: Nabil A. Alhakamy, et al.
Published: (2022-08-01)

Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect
by: Abdelwahab AF, et al.
Published: (2023-12-01)

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
by: Maryam Razzaghy-Azar, et al.
Published: (2021-10-01)

Determination of repaglinide in human plasma by high-performance liquid chromatography–tandem mass spectrometry
by: Jie Zhang, et al.
Published: (2011-06-01)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
by: Xie J, et al.
Published: (2019-04-01)

Hexyl alginate derivative, an amphiphilic innovative buccal film-forming material of promising mechanical and release characteristics for the improvement of repaglinide bioavailability
by: Khames A
Published: (2019-03-01)

Evaluating the prediction power and accuracy of two smart response surface experimental designs after revisiting repaglinide floating tablets
by: Tarek Elsayed, et al.
Published: (2024-03-01)

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
by: Rafael Gonzalo-Gobernado, et al.
Published: (2023-10-01)

Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial
by: Hosein Chiti, et al.
Published: (2017-04-01)

Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo
by: Ji-Min Kim, et al.
Published: (2021-05-01)

Pharmacokinetic Evaluation of Metabolic Drug Interactions between Repaglinide and Celecoxib by a Bioanalytical HPLC Method for Their Simultaneous Determination with Fluorescence Detection
by: Dong-Gyun Han, et al.
Published: (2019-08-01)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
by: Guoli Du, et al.
Published: (2020-10-01)

DNA oxidation and superoxide dismutase in the kidney of diabetic animals: effects of pioglitazone and repaglinide
by: Gumieniczek Anna, et al.
Published: (2006-09-01)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010-05-01)

Improved Bioavailability of Ebastine through Development of Transfersomal Oral Films
by: Nayyer Islam, et al.
Published: (2021-08-01)

Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury
by: Dao Li, et al.
Published: (2016-07-01)

Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study
by: Yuuki Akagi, et al.
Published: (2020-03-01)

Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
by: Shahinaze A. Fouad, et al.
Published: (2023-12-01)

Response surface optimization of a vortex-assisted dispersive liquid–liquid microextraction method for highly sensitive determination of repaglinide in environmental water by HPLC/UV
by: Amira H. Kamal, et al.
Published: (2022-05-01)

MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus
by: Tao Wang, et al.
Published: (2019-11-01)

An Improved Process for Repaglinide via an Efficient and One Pot Process of (1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine – A Useful Intermediate
by: Naveenkumar Kolla, et al.
Published: (2006-09-01)

Spectrophotometric determination of repaglinide in tablets based on charge-transfer complexation reaction with chloranilic acid and dichloro-dicyano benzoquinone
by: Cijo Madathil X., et al.
Published: (2011-01-01)

Bioavailability of iodine to mint from soil applied with selected amendments
by: Muhammad Mohiuddin, et al.
Published: (2019-01-01)

Ultrasensitive Electrochemical Sensor Based on SnO<sub>2</sub> Anchored 3D Porous Reduced Graphene Oxide Nanostructure Produced via Sustainable Green Protocol for Subnanomolar Determination of Anti-Diabetic Drug, Repaglinide
by: Ayyapayya Mathad, et al.
Published: (2023-01-01)

Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies
by: Niege A. J. C. Furtado, et al.
Published: (2017-03-01)

Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits
by: Shweta Sinha, et al.
Published: (2021-07-01)

The Bioavailability, Biodistribution, and Toxic Effects of Silica-Coated Upconversion Nanoparticles in vivo
by: Mingzhu Zhou, et al.
Published: (2019-04-01)

In Vivo Digestion of Egg Products Enriched with DHA: Effect of the Food Matrix on DHA Bioavailability
by: Carlos Pineda-Vadillo, et al.
Published: (2020-12-01)

A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability
by: Konrad de Vries, et al.
Published: (2021-07-01)

In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement
by: Yasir Mehmood, et al.
Published: (2020-03-01)

Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods
by: Liza Józsa, et al.
Published: (2023-04-01)

Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity
by: Mohyeldin SM, et al.
Published: (2021-03-01)

The Bioavailability of Drugs—The Current State of Knowledge
by: Marlena Stielow, et al.
Published: (2023-12-01)

The influence of food on in vivo Cd and Pb relative bioavailability in rice
by: Ping Zhuang, et al.
Published: (2023-10-01)

Corrigendum to “Pharmacognostic evaluation of Artemisia maritima L. a highly medicinal specie of genus Artemisia” [Saudi J. Biol. Sci. 29(10) (2022) 103419]
by: Shah Zaman, et al.
Published: (2022-11-01)